ARCHIVES

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

President’s Budget Versus NCI’s Bypass: A Comparison

February 21, 1992

In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three

March 12, 1976

In Brief: DCE Board Nixes NIH Intramural Postdoctural Program Magazines Rapped For Cigarette Ads

July 13, 1984

In Brief: Simone Moves To huntsman Foundation, Golde Names MSK Physician-In-Chief

January 26, 1996

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007